Jane Street Portfolio holdings
Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
T-Mobile US
TMUS
|
+$1.03B |
| 2 |
iShares Bitcoin Trust
IBIT
|
+$978M |
| 3 |
UnitedHealth
UNH
|
+$636M |
| 4 |
Nasdaq
NDAQ
|
+$575M |
| 5 |
Columbia Research Enhanced Core ETF
RECS
|
+$563M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$1.57B |
| 2 |
NVIDIA
NVDA
|
+$1B |
| 3 |
iShares Silver Trust
SLV
|
+$754M |
| 4 |
iShares Core MSCI Total International Stock ETF
IXUS
|
+$662M |
| 5 |
Microsoft
MSFT
|
+$632M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.3% |
| 2 | Financials | 1.21% |
| 3 | Consumer Discretionary | 1.07% |
| 4 | Industrials | 1.02% |
| 5 | Communication Services | 0.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
8651
PUT
Neuropace
NPCE
$490M
| $153K | ﹤0.01% |
+13,700
| New | +$171K |
|
8652
Coya Therapeutics
COYA
$110M
| $153K | ﹤0.01% |
26,540
+403
| +2% | +$2.33K |
|
|
ADVM
8653
DELISTED
Adverum Biotechnologies
ADVM
| $153K | ﹤0.01% |
+70,931
| New | +$198K |
|
8654
CALL
Direxion Daily S&P 500 High Beta Bear 3X ETF
HIBS
$18.4M
| $152K | ﹤0.01% |
+1,620
| New | +$270K |
|
8655
CALL
Navient
NAVI
$859M
| $152K | ﹤0.01% |
+10,800
| New | +$139K |
|
8656
PUT
Direxion Daily Real Estate Bull 3X ETF
DRN
$46.3M
| $152K | ﹤0.01% |
+15,900
| New | +$149K |
|
8657
PUT
Pitney Bowes
PBI
$2.2B
| $152K | ﹤0.01% |
13,900
-53,100
| -79% | -$500K |
|
8658
Children's Place
PLCE
$49.6M
| $152K | ﹤0.01% |
34,218
-29,765
| -47% | -$168K |
|
8659
CALL
AudioEye
AEYE
$104M
| $151K | ﹤0.01% |
+13,000
| New | +$155K |
|
|
MRSN
8660
DELISTED
Mersana Therapeutics
MRSN
| $151K | ﹤0.01% |
+20,447
| New | +$180K |
|
8661
CALL
Cadiz
CDZI
$271M
| $151K | ﹤0.01% |
50,500
-4,400
| -8% | -$12.6K |
|
|
KLC
8662
KinderCare Learning Companies
KLC
$303M
| $150K | ﹤0.01% |
+14,890
| New | +$172K |
|
8663
Viridian Therapeutics
VRDN
$2.62B
| $150K | ﹤0.01% |
10,737
-64,449
| -86% | -$875K |
|
8664
PUT
Emergent Biosolutions
EBS
$231M
| $150K | ﹤0.01% |
+23,500
| New | +$134K |
|
8665
ProShares UltraShort FTSE China 50 of ProShares Trust
FXP
$6.12M
| $150K | ﹤0.01% |
7,175
-234
| -3% | -$5.69K |
|
8666
PUT
Arcturus Therapeutics
ARCT
$231M
| $150K | ﹤0.01% |
+11,500
| New | +$136K |
|
8667
CALL
Petco
WOOF
$771M
| $149K | ﹤0.01% |
52,800
-71,700
| -58% | -$223K |
|
8668
Invesco DB Oil Fund
DBO
$260M
| $149K | ﹤0.01% |
11,297
-99,705
| -90% | -$1.29M |
|
|
OLO
8669
DELISTED
Olo Inc
OLO
| $149K | ﹤0.01% |
16,725
-29,640
| -64% | -$230K |
|
8670
Polen Capital International Growth ETF
PCIG
$29.7M
| $149K | ﹤0.01% |
15,095
-15,929
| -51% | -$150K |
|
8671
Genasys
GNSS
$83.3M
| $148K | ﹤0.01% |
85,681
-11,937
| -12% | -$22K |
|
8672
EyePoint Inc
EYPT
$420M
| $148K | ﹤0.01% |
+15,720
| New | +$109K |
|
8673
Sight Sciences
SGHT
$454M
| $148K | ﹤0.01% |
+35,739
| New | +$119K |
|
|
YSG
8674
PUT
Yatsen Holding
YSG
$299M
| $147K | ﹤0.01% |
+15,300
| New | +$87.7K |
|
|
KLC
8675
PUT
KinderCare Learning Companies
KLC
$303M
| $147K | ﹤0.01% |
+14,600
| New | +$169K |
|
Similar funds
Jane Street's Q2 2025 Portfolio in Review
As of Q2 2025, Jane Street held 11,384 positions worth $506B, up 27% from $397B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Jane Street deployed $36.7B of net new capital in Q2 2025, opening 2,110 new positions and adding to 3,865 existing holdings. Its largest new stake was Nasdaq: 7,205,132 shares worth $644M.
By sector, the portfolio is most concentrated in Technology at 2.3% of assets, down from 3.1% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Broadcom, an estimated $1.57B trimmed.
- Jane Street's largest Q2 2025 buy was Nasdaq: 7,205,132 shares worth $644M.
- Jane Street added most to T-Mobile US in Q2 2025, an estimated $1.03B increase.
- Jane Street's biggest Q2 2025 reduction was Broadcom, cutting an estimated $1.57B.
- Jane Street fully exited iShares Core MSCI Total International Stock ETF in Q2 2025, selling an estimated $662M.
- Jane Street's ten largest holdings make up 39% of its $506B portfolio in Q2 2025.
- Jane Street opened 2,110 new positions and closed 1,895 in Q2 2025.
- Jane Street's portfolio value rose 27% quarter-over-quarter to $506B.
Based on Jane Street's 13F filing for Q2 2025, filed 14 Aug 2025.